Capital raised by Alume Biosciences
6 Form D filings · first filed Oct 2025 · La Jolla, CA
Chief Financial Officer
Signatory on Alume Biosciences's Form D filings · $9.0M raised across 6
James Schmidt is on file as Chief Financial Officer at Alume Biosciences in La Jolla, CA. Alume Biosciences has 6 Form D filings on record, $9.0M raised in total. James Schmidt appears as a signatory on the company's filings.
An investigational peptide-dye conjugate administered intravenously roughly 60 minutes before surgery that causes nerves to fluoresce, letting surgeons see and avoid them intraoperatively. It is in Phase 3 clinical trials, with a planned FDA New Drug Application in 2026.
